Follow
Gynecology
Gynecology: the medical practice dealing with the health of the female reproductive systems (vagina, uterus, and ovaries) and the breasts. Outside medicine, the term means "the science of women". A visit to the gynecologist is recommended for annual screening and any time a woman has concerns about symptoms such as pelvic, vulvar, and vaginal pain or abnormal bleeding from the uterus.
OCT 10, 2023 | 10:00 AM
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
MAR 30, 2023 | 3:15 PM
In her presentation Prof. Staebler will share data generated by new Genomic Assessment Metrics (GIM) software for HRD assessment, and Oncomine Comprehensive Assay Plus. The samples tested we...
SEP 28, 2022 | 9:00 AM
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
APR 21, 2021 | 12:00 AM
According to the American Cancer Society, in there were an estimated 110,070 new cases diagnosed and approximately 32,120 deaths from gynecologic cancers in the U.S. in 2018. Of the five mos...
DEC 15, 2020 | 2:00 PM
Date: December 15, 2020 Time: 5:00am (PST), 8:00am (EST), 2:00pm (CET) QIAGEN proudly presents Dr. Tanja Nikolova, a leading expert in the field of obstetrics with extensive experience in...
NOV 19, 2020 | 8:00 AM
Date: November 19, 2020 Time: 8:00am PST, 11:00am EST Monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete wo...
NOV 19, 2020 | 7:00 AM
DATE: November 19, 2020 TIME: 7am PST Congenital CMV is the most frequent infectious cause of neonatal malformation in developed nations. Yet, this disease is largely under-recognized by hea...
OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies have sho...
OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical research studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
OCT 08, 2020 | 12:00 AM
Learning Objectives: 1. To provide an overview of relevant hereditary cancer syndromes 2. To encourage providers to obtain a thorough family history 3. To educate providers about available r...
